| All | sRAI- | sRAI +  | p |
---|---|---|---|---|
N (%cohort) | 363 | 223 (61) | 140 (39) | – |
Age, years | 9.6 (3.3–16.3) | 10.3 (4.1–16.3) | 8.6 (2.2–15.9) | 0.06 |
Male sex, n (%) | 187 (52) | 106 (48) | 81 (58) | 0.06 |
History of Transplant | 34 (9) | 10 (4) | 24 (17) |  < 0.001 |
Severity of Illness | ||||
PRISM III | 8 (5–13) | 7 (3–10) | 12 (8–17) |  < 0.001 |
PERSEVERE-II Mortality Probability | 0.007 (0.007–0.189) | 0.007 (0.007–0.019) | 0.167 (0.007–0.325) |  < 0.001 |
Baseline SCr, mg/dl | 0.36 (0.24–0.49) | 0.38 (0.26–0.52) | 0.33 (0.22–0.47) | 0.012 |
Baseline Known, n (%) | 205 (56) | 127 (57) | 78 (56) | 0.82 |
D1 Vasoactive Medications, n (%) D1 VIS | 268 (74) 7.0 (0–18) | 138 (62) 4.0 (0–10) | 130 (93) 14.5 (6–27.8) |  < 0.001  < 0.001 |
D1 Mechanical Ventilation, n (%) | 202 (56) | 87 (39) | 115 (82) |  < 0.001 |
D1 Fluid Balance (%FB) | 3.9 (1.3–7.1) | 3.4 (1.1–6.3) | 4.9 (1.7–8.9) | 0.001 |
D1 SCr > Baseline | 1.3 (0.96–2.1) | 1.1 (0.9–1.4) | 2.2 (1.3–3.6) |  < 0.001 |
D1 Platelet Count (× 103/uL) | 153 (70–265) | 188 (105–305) | 98 (45–170) |  < 0.001 |
D3 Severe AKI, n (%) | 79 (22) | 12 (5) | 67 (48) |  < 0.001 |
Relative Risk Severe AKI | – | – | RR 8.9 (5–16) |  < 0.001 |
D1-7 KRT Use, n (%) | 49 (13) | 4 (2) | 45 (32) |  < 0.001 |
Relative Risk KRT Use | – | – | RR 18 (6.6–49) |  < 0.001 |
PICU Free Days | 22 (10–26) | 25 (19–26) | 14.5 (0–23) |  < 0.001 |
28-day Mortality, n (%) | 26 (7.2) | 10 (4) | 16 (11) | 0.013 |
Relative Risk Mortality | – | – | RR 2.5 (1.2–5.5) | 0.013 |